title: Influence of gender and age on the survival of patients with nasopharyngeal carcinoma.
abstract: BACKGROUND
  The prognostic value of gender and age in the survival of nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT) is unclear. Several studies have suggested a female advantage in the prognosis of solid tumors. We investigated the relationship between gender differences and disease outcome in NPC patients treated with IMRT in South China.
  
  
  METHODS
  A total of 299 patients with non-disseminated NPC were analyzed retrospectively. IMRT was delivered with a simultaneous modulated, accelerated radiotherapy boost technique at prescribed doses of 70 Gy/30 fractions/6 weeks to the primary tumor (GTVp) and positive neck nodes (GTVn), 60Gy (2.0 Gy/day) to the clinical target volume (CTV) and upper neck region and 54 Gy (1.8 Gy/day) to the clinically negative low neck. A median boost dose of 9.2 Gy (4-20 Gy) was administered to patients with persistent disease at the primary site.
  
  
  RESULTS
  With a median follow-up of 52 months, the male patients had a significantly unfavorable 5-year OS (70.7% compared to 94.1%, P < 0.001), DPFS (71.5% compared to 87.3%, P = 0.029) and DMFS (77.2% compared to 89.7%, P = 0.036) than the female patients. In patients younger than 45, the male patients had a poorer 5-year OS (66.8% compared to 91.2%, P = 0.008), DPFS (59.9% compared to 91.2%, P = 0.005) and DMFS (66.4% compared to 94.0%, P = 0.004) than the female patients. For patients older than 45, only the 5-year OS (72.2% compared to 96.0%, P = 0.001) was significantly different.
  
  
  CONCLUSIONS
  Gender and age are strong independent prognostic factors for NPC in this study. We are the first to report that younger male patients were more likely to have distant metastases and exhibited inferior overall survival and disease progression-free survival rates compared to other patients.
authors: Guangli
authors: G
authors: Xiao
authors: Yabing
authors: Y
authors: Cao
authors: Xibin
authors: X
authors: Qiu
authors: Weihua
authors: W
authors: Wang
authors: Yufeng
authors: Y
authors: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000532:radiotherapy; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal; D050397:Radiotherapy, Intensity-Modulated; D012189:Retrospective Studies; D012737:Sex Factors; D015996:Survival Rate; D055815:Young Adult
references: Clin Dermatol. 2010 May-Jun;28(3):287-92
references: 20541681
references: J Clin Oncol. 2012 Jun 20;30(18):2240-7
references: 22547594
references: Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):161-8
references: 16542792
references: Cancer Causes Control. 2008 Jun;19(5):437-42
references: 18197460
references: Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1107-16
references: 15752890
references: Cancer J. 2010 Jan-Feb;16(1):62-5
references: 20164692
references: Br J Cancer. 1991 Jun;63(6):986-92
references: 1648949
references: Clin Chim Acta. 2008 Sep;395(1-2):124-9
references: 18588866
references: Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):672-9
references: 15936544
references: Breast Cancer Res. 2012 Feb 09;14(1):R27
references: 22321971
references: PLoS One. 2012;7(12):e52457
references: 23300677
references: Br J Radiol. 2009 Jun;82(978):452-8
references: 19451314
references: Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1181-9
references: 11483327
references: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1082-9
references: 18410997
references: Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):661-8
references: 20643517
references: Int J Cancer. 1989 Apr 15;43(4):685-91
references: 2539332